REGN: second_quarter 2026 lobbying report

{"url":"https://lda.gov/api/v1/filings/3226fb00-77e7-4241-886e-3c0c50a1b3af/","filing_uuid":"3226fb00-77e7-4241-886e-3c0c50a1b3af","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/3226fb00-77e7-4241-886e-3c0c50a1b3af/print/","filing_document_content_type":"text/html","income":"50000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Steven E Crane","dt_posted":"2026-08-03T14:47:04-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"7424 Beverly Manor Drive","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Annandale","registrant_state":"VA","registrant_zip":"22003","registrant":{"id":400927689,"url":"https://lda.gov/api/v1/registrants/400927689/","house_registrant_id":null,"name":"CRANE STRATEGIES","description":"Government relations consulting","address_1":"7424 Beverly Manor Drive","address_2":null,"address_3":null,"address_4":null,"city":"Annandale","state":"VA","state_display":"Virginia","zip":"22003","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"STEVEN E. CRANE","contact_telephone":"+1 571-217-4058","dt_updated":"2026-08-03T14:49:24.855102-04:00"},"client":{"id":196249,"url":"https://lda.gov/api/v1/clients/196249/","client_id":48,"name":"REGENERON PHARMACEUTICALS, INC.","general_description":"Biopharmaceutical development and manufacturing","client_government_entity":false,"client_self_select":null,"state":"NY","state_display":"New York","country":"US","country_display":"United States of America","ppb_state":"NY","ppb_state_display":"New York","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2019-01-15"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Biodefense and Medicare prescription drug funding","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":56432,"prefix":null,"prefix_display":null,"first_name":"STEVEN","nickname":null,"middle_name":null,"last_name":"CRANE","suffix":null,"suffix_display":null},"covered_position":"Staff assistant, Senator Barbara Mikulski","new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}